We want to thank you for stopping by to celebrate a milestone year with us at EANM (European Association of Nuclear Medicine). We hope you found it as exciting and productive as we did.
At the show you had the opportunity to see our recent developments, like Biograph Vision and attend live clinical presentations. But if you didn’t have a chance to see us in person, you can still learn about the highlights at our booth.
Be sure to save the date for next year’s meeting held October 12 -16. We look forward to seeing you at EANM 2019 in Barcelona, Spain.
Subscribe to our newsletter and stay up-to-date on new products and industry trends. We hope to see you at the upcoming SNMMI.
The next-generation of PET/CT scanners that empowers you to see a whole new world of precision. It goes beyond digital to reveal the bigger picture, maximize efficiency and help you to better understand disease progression.
Biograph Horizon Flow edition
The new Biograph Horizon™ Flow1 edition with FlowMotion™ technology enables standardized indication-based protocols, adjusted to the patients anatomy, all in a single scan.
Biograph mCT Flow
Biograph mCT FlowTM1 with FlowMotion technology combines our standard-setting PET/CT with a unique system design that enables continuous motion of the patient table—allowing increased image quality, greater patient comfort, better performance and expanded versatility.
FlowMotion continuous bed motion technology, enables standardized indication-based protocols, adjusted to the patient’s anatomy, all in a single scan–-personalizing the patient experience while optimizing the workflow.
With Biograph mMR MR/PET you can set the pace in diagnostic imaging, by combining leading 3T MRI performance with proven molecular imaging, fully integrated in one system.
Symbia Intevo Bold
A better image quality for those who want more from SPECT/CT. We made high-performance CT even better with the Symbia Intevo Bold™1.
Priorities in healthcare are shifting. Better care no longer means more care. It means more effective care. Now, you can discover expanded clinical reach and a higher standard of care and distinction for your organization−with the hybrid SPECT/CT technology of Symbia Intevo.TM
Expanded xSPECT QuantTM1 now offers automated, accurate and reproducible quantification of 99mTc, 123I, 177Lu and 111In. This extends the use of advanced SPECT/CT quantification from general nuclear medicine and bone studies to indications including neurological disorders, neuroendocrine tumors, neuroblastoma and metastatic prostate cancer. xSPECT BoneTM provides higher resolution and increased clinical detail to support physicians’ ability to more confidently characterize disease state. xSPECT,™ the true integration of SPECT and CT.
syngo.via for MI
Save time, cost and effort with one reading solution engineered for greater productivity and accuracy: syngo® .via for Molecular Imaging is available for both PET/CT, SPECT and SPECT/CT.
PETNET Solutions Inc. a Siemens Healthineers Company
PETNET Solutions support the growth of our customers’ business with one-time delivery of PET tracers and comprehensive value-added services
The Dosimetry Research Tool shown in the image is an Investigational Device. Limited by Federal (or United States) law to investigational use. This device is exclusively for clinical investigations. This Investigational Device does not fulfill all the essential requirements according to the European Medical Device Directive (93/42/EEC) and its national implementations. It is not commercially available in the European Union, or other countries worldwide.
1Biograph Vision, Biograph Horizon Flow edition, Biograph mCT Flow, Symbia Intevo Bold, and xSPECT Quant are not commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed. Please contact your local Siemens organization for further details.